References 1 Liu NH et al . Excess mortality in persons with severe mental disorders : a multilevel intervention framework and priorities for clinical practice , policy and research agendas . World Psychiatry 2017 ; 16 ( 1 ): 30 – 40 . 2 World Health Organization . Guidelines for the management of physical health conditions in adults with severe mental disorders . Geneva ; 2018 . 3 Walker ER , McGee RE , Druss BG . Mortality in mental disorders and global disease burden implications a systematic review and meta-analysis . JAMA Psychiatry 2015 ; 72 ( 4 ): 334 – 41 . 4 Popovic D et al . Risk factors for suicide in schizophrenia : Systematic review and clinical recommendations . Acta Psychiatr Scand 2014 ; 130 ( 6 ): 418 – 26 . 5 Hoang U , Goldacre MJ , Stewart R . Avoidable mortality in people with schizophrenia or bipolar disorder in England . Acta Psychiatr Scand 2013 ; 127 ( 3 ): 195 – 201 . 6 Joukamaa M et al . Schizophrenia , neuroleptic medication and mortality . Br J Psychiatry 2006 ; 188:122 – 7 . 7 Ösby U et al . Mortality and causes of death in schizophrenia in Stockholm County , Sweden . Schizophr Res 2000 ; 45 ( 1 – 2 ): 21 – 8 . 8 Colombo M . Reflexivity and narratives in action research : A discursive approach [ Internet ]. Forum : Qualitative Social Research . 2003 . www . qualitativeresearch . net / index . php / fqs / article / view / 718 ( accessed July 2022 ). 9 Fors BM , Isacson D , Bingefors K , Widerlöv B . Mortality among persons with schizophrenia in Sweden : An epidemiological study . Nord J Psychiatry 2007 ; 61 ( 4 ): 252 – 9 . 10 Dag T et al . Excess mortality in persons with severe mental disorder in Sweden : A cohort study of 12 103 individuals with and without contact with psychiatric services . Clin Pract Epidemiol Ment Health 2008 ; 4 ( 23 ). 11 Lawrence D , Kisely S , Pais J . The epidemiology of excess mortality in people with mental illness . Can J Psychiatry 2010 ; 55 ( 12 ): 752 – 60 . 12 Saha S , Chant D , McGrath J . A systematic review of mortality in schizophrenia : Is the differential mortality gap worsening over time ? Arch Gen Psychiatry 2007 ; 64 ( 10 ): 1123 – 31 . 13 Koschorke M et al . Experiences of stigma and discrimination faced by family caregivers of people with schizophrenia in India . Soc Sci Med 2017 ; 178:66 – 77 . 14 Correll CU et al . Prevalence , incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness : a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls . World Psychiatry 2017 ; 16 ( 2 ): 163 – 80 . 15 Vinogradova Y et al . Effects of severe mental illness on survival of people with diabetes . Br J Psychiatry 2010 ; 197 ( 4 ): 272 – 7 . 16 Becker T , Hux J . Risk of acute complications of diabetes among people |
with schizophrenia in Ontario , Canada . Diabetes Care 2011 ; 34 ( 2 ): 398 – 402 . 17 Mitchell AJ et al . Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis . Schizophr Bull 2013 ; 39 ( 2 ): 306 – 18 . 18 Nasrallah HA et al . Low rates of treatment for hypertension , dyslipidemia and diabetes in schizophrenia : data from the CATIE schizophrenia trial sample at baseline . Schizophr Res 2006 ; 86 ( 1 – 3 ): 15 – 22 . 19 Pérez-Piñar M et al . Cardiovascular risk factors among patients with schizophrenia , bipolar , depressive , anxiety , and personality disorders . Eur Psychiatry 2016 ; 35:8 – 15 . 20 The Health and Social Care Information Centre ( HSCIC ). Statistics on smoking : Smoking rates in people with serious mental illness : England , 2016 . www . digital . nhs . uk / data-andinformation / publications / clinicalindicators / ccg-outcomes-indicator-set / archive / ccg-outcomes-indicator-set--- march-2016 ( accessed July 2022 ). 21 Centers for Disease Control and Prevention . Best Practices User Guide : Health Equity in Tobacco Prevention and Control [ Internet ]. 2015 . www . cdc . gov / tobacco / stateandcommunity / bestpractices-health-equity / pdfs / ( accessed July 2022 ). 22 Holt R , Peveler R . Obesity , serious mental illness and antipsychotic drugs . Diabetes Obes Metab 2009 ; 11 ( 7 ): 665 – 79 . 23 Allison D et al . Obesity among those with mental disorders : a National Institute of Mental Health meeting report . Am J Prev Med 2009 ; 36 ( 4 ): 341 – 50 . 24 Teasdale SB et al . Dietary intake of people with severe mental illness : Systematic review and meta-analysis . Br J Psychiatry 2019 ; 214 ( 5 ): 251 – 9 . 25 Angst F et al . Mortality of patients with mood disorders : follow-up over 34-38 years . J Affect Disord 2002 Apr 1 ; 68 ( 2 – 3 ): 167 – 81 . 26 Casey D . Metabolic issues and cardiovascular disease in patients with psychiatric disorders . Am J Med [ Internet ]. 2005 ; 118 ( S2 ): 15S-22S . 27 Heiskanen T et al . Metabolic syndrome in patients with schizophrenia . J Clin Psychiatry 2003 ; 64 ( 5 ): 575 – 9 . 28 World Health Organization . Mental Health Action Plan 2013 – 2020 . www . who . int / mental _ health / action _ plan _ 2013 / en / ( accessed July 2022 ). 29 Dregan A et al . Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom . PLoS One 2020 ; 15 ( 3 ): e0230674 . 30 Lamontagne-Godwin F et al . Interventions to increase access to or uptake of physical health screening in people with severe mental illness : A realist review . BMJ Open 2018 ; 8 ( 2 ): e019412 . 31 De Hert M et al . Physical illness in patients with severe mental disorders . I . Prevalence , impact of medications |
and disparities in health care . World Psychiatry 2011 ; 10:52 – 77 . 32 De Hert M et al . Physical illness in patients with severe mental disorders . II . Barriers to care , monitoring and treatment guidelines , plus recommendations at the system and individual level . World Psychiatry 2011 ; 10 ( 2 ): 138 – 51 . 33 Lawrence DM et al . Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980- 1998 . Br J Psychiatry 2003 ; 182:31 – 6 . 34 Kisely S , Campbell LA , Wang Y . Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare . Br J Psychiatry 2009 ; 195 ( 6 ): 545 – 50 . 35 Crump C et al . Comorbidities and mortality in persons with schizophrenia : A Swedish national cohort study . Am J Psychiatry 2013 ; 170 ( 3 ): 324 – 33 . 36 Laursen TM et al . Somatic hospital contacts , invasive cardiac procedures , and mortality from heart disease in patients with severe mental disorder . Arch Gen Psychiatry 2009 ; 66 ( 7 ): 713 – 20 . 37 Cooper SJ et al . BAP guidelines on the management of weight gain , metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment . J Psychopharmacol 2016 ; 30 ( 8 ): 717 – 48 . 38 Leucht S et al . Second-generation versus first-generation antipsychotic drugs for schizophrenia : a meta-analysis . Lancet 2009 ; 373 ( 9657 ): 31 – 41 . 39 Jones B et al . Weight change and atypical antipsychotic treatment in patients with schizophrenia . J Clin Psychiatry 2001 ; 62 ( S2 ): 41 – 4 . 40 Kinon BJ et al . Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders . J Clin Psychopharmacol 2005 ; 25 ( 3 ): 255 – 8 . 41 Basu A , Meltzer HY . Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era . Schizophr Res 2006 ; 86 ( 1 – 3 ): 99 – 109 . 42 Pillinger T et al . Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia , predictors of metabolic dysregulation , and association with psychopathology : a systematic review and network meta-analysis . Lancet Psychiatry 2020 ; 7 ( 1 ): 64 – 77 . 43 Tiihonen J et al . 11-year follow-up of mortality in patients with schizophrenia : a population-based cohort study ( FIN11 study ). Lancet 2009 ; 374 ( 9690 ): 620 – 7 . 44 Taipale H et al . Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia . Schizophr Bull 2021 ; 47 ( 1 ): 23 – 30 . 45 Victorian Mental Health Services . Improved Access Through Co-Ordinated Client Care 94 / 0285 . Melbourne ; 1995 . 46 National Institute for Health and Care Excellence . Schizophrenia : Core |
Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care . London ; 2002 . 47 American Diabetes Association , American Psychiatric Association , American Association of Clinical Endocrinologists , and North American Association for the Study of Obesity . Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes . Diabetes Care 2004 ; 27 ( 2 ): 596 – 601 . 48 Lambert TJR et al . Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment , management and monitoring of the physical health of people with an enduring psychotic illness . Aust N Z J Psychiatry 2017 ; 51 ( 4 ): 322 – 37 . 49 National Institute for Health and Care Excellence . Psychosis and schizophrenia in adults . NICE guidelines on treament and management . 2014 . www . nice . org . uk / guidance / cg178 / evidence / fullguideline-490503565 ( accessed July 2022 ). 50 National Institute for Health and Care Excellence . Psychosis and schizophrenia in adults : prevention and management . Clinical guideline CG178 . www . nice . org . uk / guidance / cg178 ( accessed July 2022 ). 51 Buchanan R et al . The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements . Schizophr Bull 2010 ; 36 ( 1 ): 71 – 93 . 52 Mitchell A et al . Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication : systematic review and meta-analysis of screening practices . Psychol Med 2012 ; 42 ( 1 ): 125 – 47 . 53 Druss BG , Bornemann TH . Improving health and health care for persons with serious mental illness : The window for US federal policy change . J Am Med Assoc 2010 ; 303 ( 19 ): 1972 – 3 . 54 Sud D et al . The role of pharmacy in the management of cardiometabolic risk and metabolic syndrome in severe mental illness : a mixed methods review . BMC Syst Rev 2021 ; 10 ( 1 ): 1 – 35 . 55 Hippisley-Cox J , Coupland C , Brindle P . QRISK risk calculator [ Internet ]. 2018 https :// qrisk . org / ( accessed July 2022 ). 56 LESTER UK Adaptation 2014 . Positive Cardiometabolic Health Resource . [ Internet ]. 2014 . www . rcpsych . ac . uk / docs / default-source / improving-care / ccqi / national-clinicalaudits / ncap-library / ncap-e-versionnice-endorsed-lester-uk-adaptation . pdf ? sfvrsn = 39bab4 _ 2 ( accessed July 2022 ). 57 Sud D . Cardiometabolic risk , metabolic syndrome and related diseases in severe mental illness : the role of pharmacy in the lived experience of patients [ Internet ]. Aston University ; 2021 . https :// publications . aston . ac . uk / id / eprint / 43476 / 6 / SUD _ DOLLY _ 2021v2 . pdf ( accessed July 2022 ). |